Long-term prognosis of antiepilpetic drug therapy in people with newly diagnosed and treated epilepsy
- Research Opportunity
- PhD, Masters by Research, Honours
- Project Status
- Medicine and Radiology
- Royal Melbourne Hospital
|Patrick Kwan||Personal web page|
Antiepileptic drug is the mainstay of treatment modality for epilepsy. People with epilepsy often require lifelong antiepileptic drug treatment. Previous Glasgow study in 2000 demonstrated a-third of the epilepsy patient did not response well to antiepileptic drug therapy. Despite the introduction of more than a dozen new antiepileptic drugs in the past two decades, there remain no robust data to suggest improvement in treatment outcomes in the recent expanded Glasgow study. To valid the prognosis and antiepileptic drug response patterns observed in the Glasgow studies.
We will assess treatment outcomes of 796 newly treated epilepsy patients who were seen at a First Seizure Clinic between 1 May 1999 and 31 May 2016 and were prospectively followed for up to 16 years in Australia. We will extract seizure, diagnostic and treatment information from baseline and follow-up clinical documents and construct a digital database. The prognosis and response patterns in the Australia cohort will be compared with the findings in the Glasgow study.
This research project is available to PhD, Masters by Research, Honours students to join as part of their thesis.
Please contact the supervisor to discuss your options.
Faculty Research Themes
School Research Themes
For further information about this research, please contact a supervisor.